Clinical Trial Update: Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating silymarin to prevent new-onset atrial fibrillation after cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: University of Novi Sad | Conditions: Atrial Fibrillation New Onset | Phase 3 | Status: COMPLETED